Cargando…
Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
OBJECTIVE: Organoids have recently been used as in vitro models to screen chemotherapy drugs in combination with hyperthermia treatment in colorectal cancer. Our research aimed to establish a library of patient-derived colorectal cancer organoids to evaluate synergism between chemotherapy drugs and...
Autores principales: | Zeng, Lisi, Liao, Quanxing, Zhao, Haoran, Jiang, Shengwei, Yang, Xianzi, Tang, Hongsheng, He, Qingjun, Yang, Xiansheng, Fang, Shuxian, He, Jinfu, Cui, Weiwen, Huang, Laiqiang, Ma, Shaohua, Cui, Shuzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330527/ https://www.ncbi.nlm.nih.gov/pubmed/33710819 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0566 |
Ejemplares similares
-
Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer
por: Zeng, Lisi, et al.
Publicado: (2022) -
An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
por: Jiang, Shengwei, et al.
Publicado: (2020) -
Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
por: Lei, Ziying, et al.
Publicado: (2020) -
Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study
por: Lei, Ziying, et al.
Publicado: (2020) -
Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)